Showing results (31-40 of 681) with videos related to
Sort By:
Pageof 69
Expert Review of Vaccines|February 7, 2007
Development of vaccines for Marburg hemorrhagic feverDaniel G Bausch, Thomas W GeisbertExpert Reviews in Molecular Medicine|September 24, 2004
Ebola virus: new insights into disease aetiopathology and possible therapeutic interventionsThomas W Geisbert, Lisa E HensleyTrends in Molecular Medicine|July 13, 2017
Neutralizing the Threat: Pan-Ebolavirus Antibodies Close the LoopChad E Mire, Thomas W GeisbertJournal of Virology|September 16, 2006
Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccineKathleen M Daddario-DiCaprio, Thomas W Geisbert, Joan B Geisbert, et al.Thrombosis and Haemostasis|August 23, 2005
The contribution of the endothelium to the development of coagulation disorders that characterize Ebola hemorrhagic fever in primatesLisa E Hensley, Thomas W GeisbertMethods in Molecular Biology (Clifton, N.J.)|June 3, 2017
Evaluation of Medical Countermeasures Against Ebolaviruses in Nonhuman Primate ModelsChad E Mire, Thomas W GeisbertThe Journal of Infectious Diseases|December 6, 2007
In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent proteinHideki Ebihara, Steven Theriault, Gabriele Neumann, et al.Scientific Reports|October 13, 2015
The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onsetDavid Safronetz, Kyle Rosenke, Jonna B Westover, et al.The Journal of Infectious Diseases|July 20, 2023
Limited Benefit of Postexposure Prophylaxis With VSV-EBOV in Ebola Virus-Infected Rhesus MacaquesTrenton Bushmaker, Friederike Feldmann, Jamie Lovaglio, et al.Methods in Molecular Biology (Clifton, N.J.)|May 17, 2017
Reverse Genetics Systems for FilovirusesThomas Hoenen, Heinz FeldmannPageof 69